Increased levels of epidermal growth factor in the sputum of smoking patients with chronic bronchitis

International Review of Allergology and Clinical Immunology

Volumn 12, Issue 1, 2006, Pages 12-17

  Barczyk, Adam ^a   Sozańska, Ewa ^a   Pierzchała, Władysław ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Chronic bronchitis; COPD; EGF; Induced sputum

Indexed keywords

EPIDERMAL GROWTH FACTOR;

ADULT; AGED; ARTICLE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FEMALE; HUMAN; LYMPHOCYTE COUNT; MACROPHAGE; MALE; SMOKING; SPIROMETRY; SPUTUM;

EID: 33646046481     PISSN: 12329142     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Pauwels R.A., Buist A.S., Calverley P.M.A., Jenkins C.R., Hurd S.S.: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med., 2001, 163, 1256-1276.
2. Trevisani L., Sartori S., Bovolenta M.R., et al.: Structural characterization of the bronchial epithelium of subjects with chronic bronchitis and in asymptomatic smokers. Respiration, 1992, 59, 136-144.
3. Spurzem J.R., Thompson A.B., Daughton D.M., Mueller M., Linder J., Rennard S.I.: Chronic inflammation is associated with an increased proportion of goblet cells recovered by bronchial lavage. Chest, 1991, 100, 389-393.
4. Takeyama K., Dabbagh K., Lee H.M., et al.: Epidermal growth factor system regulates mucin production in airways. Proc. Natl Acad. Sci. USA, 1999, 96, 3081-3086.
5. Takeyama K., Jung B., Shim J.J., et al.: Activation of epidermal growth factor receptors is responsible for mucin synthesis induced by cigarette smoke. Am. J. Physiol. Lung Cell. Mol. Physiol., 2001, 280, L165-L172.
6. Pavord I.D., Pizzichini M.M., Pizzichini E., Hargreave F.E.: The use of induced sputum to investigate airway inflammation. Thorax, 1997, 52, 498-501.
7. Barczyk A., Pierzchala W., Sozanska E.: Levels of CC-chemokines (MCP-1, MIP-1a, MIP-1b) in induced sputum of patients with chronic obstructive pulmonary disease and patients with chronic bronchitis. Pneumonol. Alergol. Pol., 2001, 69, 40-49.
8. Sterk P.J., Fabbri L.M., Quanjer P.M., et al.: Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur. Respir. J., 1993, 16, 53-83.
9. Lamb D.J., Modjtahedi H., Plant N.J., Ferns G.A.: EGF mediates monocyte chemotaxis and macrophage proliferation and EGF receptor is expressed in atherosclerotic plaques. Atherosclerosis, 2004, 176, 21-26.
10. Madtes D.K., Busby H.K., Strandjord T.P., Clark J.G.: Expression of transforming growth factor-alpha and epidermal growth factor receptor is increased following bleomycin-induced lung injury in rats. Am. J. Respir. Cell Mol. Biol., 1994, 11, 540-551.
11. Gudbjomsson B., Hallgren R., Nettelbladt O., et al.: Phenotypic and functional activation of alveolar macrophages, T lymphocytes and NK cells in patients with systemic sclerosis and primary Sjogren's syndrome. Ann. Rheum. Dis., 1994, 53, 574-579.
12. Barczyk A., Pierzchala W., Sozanska E.: Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir. Med., 2003, 97, 726-733.